packageTeplizumab

teplizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Teplizumab is a monoclonal antibody used to treat type 1 diabetes. It is authorised in the European Union and also approved elsewhere, though it remains partly investigational.

Summary written by glm-5.3-flash from Wikidata Q7701358 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:teplizumab
ATC codes:A10XX01
DrugBank:DB06606
Wikidata:Q7701358
molar mass:150000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown